Jonathan J. Duplisea

Author

The University of Texas MD Anderson Cancer Center

Also Known As

Jonathan Duplisea, Jonathan J Duplisea, Jonathan J. Duplisea, Jonathan James Duplisea

Publications

359

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Johns Hopkins University University of Cincinnati

About

Jonathan J. Duplisea is an author at The University of Texas MD Anderson Cancer Center specializing in surgery, medicine, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	68
2	Surgical Oncology	2	2	68
3	Robotics	1	1	46
4	Oncology	1	1	22
5	Outcomes Research	1	1	22

Jonathan J. Duplisea

Publications

300

Citations

H-Index

Page 1

	Year	Citations
Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer Charles C. Guo, Tadeusz Majewski, Li Zhang, Cell Reports	2019	146
Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer Roger Li, Jonathan J. Duplisea, Firas G. Petros, European Urology Oncology UrologySurgical OncologyTesticular CancerMedicineRobotic Surgery	2019	46
Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma Jonathan J. Duplisea, Ross Mason, Chad A. Reichard, Canadian Urological Association Journal	2018	42
Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members Justin T. Matulay, William Tabayoyong, Jonathan J. Duplisea, Urologic Oncology Seminars and Original Investigations Urological ResearchUrologySurgical OncologyUrologic Cancer EpidemiologyGenitourinary Cancer	2020	22
Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer Charles C. Guo, Tadeusz Majewski, Li Zhang,	2018	21
Lentiviral interferon: A novel method for gene therapy in bladder cancer Sharada Mokkapati, Vikram M. Narayan, Ganiraju C. Manyam, Molecular Therapy — Oncolytics	2022	13
Oncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience Andrea Kokorovic, Jonathan J. Duplisea, Wei Qiao, Urologic Oncology Seminars and Original Investigations	2021	10

Page 1